{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-125356","form_type":"8-K","ticker":"CYPH","cik":"0001509745","company_name":"CYPHERPUNK TECHNOLOGIES INC.","filed_at":"2023-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.312206+00:00","generated_at":"2026-06-07T14:08:22.777411+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Leap Therapeutics sells IL-1ß antibody assets to AlmataBio for $500K cash plus up to $70M milestones","bullets":["Entered into Asset Purchase Agreement with AlmataBio for IL-1ß antibodies FL-101 and FL-103.","Received $500,000 cash at closing; potential milestone payments up to $70 million tied to regulatory and sales milestones.","Buyer assumed all liabilities related to the transferred assets.","80% of after-tax net proceeds from sale to be paid to former Flame Biosciences equityholders as additional merger consideration."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-125356","json":"https://secwatch.observer/filing/0001104659-23-125356.json","markdown":"https://secwatch.observer/filing/0001104659-23-125356.md","text":"https://secwatch.observer/filing/0001104659-23-125356.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1509745/000110465923125356/0001104659-23-125356-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1509745/000110465923125356/tm2332656d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T14:08:22.777411+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}